MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Case report: Parkinsonim with dyskinesia secondary to amyloid angiopathy

    K. Khelfaoui Tredano, G. Berrada, Y. Hsaini, A. Benomar, H. Tibar (Rabat, Morocco)

    Objective: To report a case of parkinsonism secondary to amyloid angiopathy and discuss the pathophysiology and treatment of this entity. Background: Cerebral amyloid angiopathy is…
  • 2022 International Congress

    Levodopa Carbidopa Intestinal Gel in Patients with Deep Brain Stimulation in Parkinson’s disease- First case series from Middle-East Region

    S. Mittal, A. Aldakheel, W. Mohammed, T. Alkhairallah, B. Klassen, M. Thomas, T. Maiti, S. Wasti (Abu Dhabi, United Arab Emirates)

    Objective: The objective is to report unique and challenging cases, who had successful control of Parkinson’s disease (PD) symptoms with combination therapy of Deep Brain…
  • 2022 International Congress

    NPC1 is not a PD risk factor gene

    G. Barrel, M. Olmedillas, K. Kandaswamy, A. Westenberger, G. Hartmann, C. Klein, P. Bauer, C. Beetz (Rostock, Germany)

    Objective: To test the hypothesis of NPC1 to be a PD risk factor gene. Background: The many etiologies of PD include genetic risk factors. The…
  • 2022 International Congress

    A Case of Neurodegeneration with Brain Iron Accumulation with novel Adaptor Protein-4 M1 subunit mutation

    A. Battineni, D. Vijayakumar (Greenville, USA)

    Objective: To present a patient with clinical and radiological features of neurodegeneration with brain iron accumulation (NBIA) due to a novel variant mutation in adaptor…
  • 2022 International Congress

    Fragile X Associated Tremor and Ataxia Syndrome (FXTAS) presents with widespread reactive gliosis and white-matter specific astrocyte degeneration

    B. Dufour, V. Martínez-Cerdeño (Sacramento, USA)

    Objective: We will characterize neuropathological alterations of astrocytes in different regions of the FXTAS brain. Background: FXTAS is a progressive neurodegenerative disorder that occurs in…
  • 2022 International Congress

    Phase 2 study evaluating safety, PK/PD, biomarkers, and efficacy of ANX005 in patients with Huntington’s disease (HD)

    R. Kumar, D. Claassen, A. Mongan, A. Grover, B. Hoehn, P. Lin, R. Arnold, E. Cahir-Mcfarland, T. Yednock, S. Keswani (Englewood, USA)

    Objective: To assess the safety, PK/PD, exploratory biomarkers, and efficacy of ANX005 in patients with, or at risk for, manifest HD. Background: Increased complement activation…
  • 2022 International Congress

    “Belly Dance Tremor” – Hip and Truncal tremor in Parkinson’s disease

    S. Mittal, T. Maiti (Abu Dhabi, United Arab Emirates)

    Objective: To report unusual presentation of Young-Onset Parkinson’s disease with disabling hip and trunk rest tremor resembling “belly dance”. Background: Proximal tremor is not commonly…
  • 2022 International Congress

    Reconfiguration of Functional Motor Connectome after MRgFUS Vim Thalamotomy in Essential Tremors

    M. Stanziano, S. Palermo, JP. Medina, G. Demichelis, D. Fedeli, G. Messina, N. Golfrè Andreasi, S. Rinaldo, A. Redolfi, G. Devigili, V. Levi, F. Ghielmetti, G. Frazzetta, L. D'Incerti, M. Grisoli, F. Di Meco, A. Nigri, MG. Bruzzone, R. Eleopra (Milan, Italy)

    Objective: Our primary endpoint was to verify whether rs-FC between tremor-related areas was effectively modulated by MRgFUS at 1 and 3 months post-operatively.  Alongside, we…
  • 2022 International Congress

    Evaluation of ocular perfusion in Parkinson’s disease and association with clinical manifestations.

    A. Camacho-Ordonez, M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Hernández-Medrano, O. Guerrero-Berger (Mexico, Mexico)

    Objective: To evaluate optic nerve head and macular perfusion in subjects with Parkinson's disease (PD) and its association with clinical manifestations. Background: PD is associated…
  • 2022 International Congress

    COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, S. Umutbaev, O. Kachemaeva, A. Baitimerov, R. Galimova, R. Magzhanov (Ufa, Russian Federation)

    Objective: We examined the influence of single nucleotide polymorphisms (SNPs) in specific genes on levodopa-induced dyskinesia development in Parkinson’s disease patients Background: Levodopa-induced dyskinesia (LID)…
  • « Previous Page
  • 1
  • …
  • 809
  • 810
  • 811
  • 812
  • 813
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley